• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童在 COVID-19 家庭传播中的作用:系统评价和荟萃分析。

The role of children in household transmission of COVID-19: a systematic review and meta-analysis.

机构信息

Department of Neonatology, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China.

Department of Neonatology, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China.

出版信息

Int J Infect Dis. 2022 Sep;122:266-275. doi: 10.1016/j.ijid.2022.05.016. Epub 2022 May 11.

DOI:10.1016/j.ijid.2022.05.016
PMID:35562045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9091150/
Abstract

OBJECTIVES

To explore household transmissibility of SARS-CoV-2 in children in new-variants dominating periods.

METHODS

Through retrieval in PubMed and Embase, studies were included in two parts: meta-analysis of the household secondary attack rate (SAR) and case analysis of household pediatric infections.

RESULTS

A total of 95 articles were included: 48 for meta-analysis and 47 for case analysis. Pediatric COVID-19 only comprised a minority of the household transmission. The total pooled household SAR of child index cases and contacts were 0.20 (95% confidence interval [CI]: 0.15-0.26) and 0.24 (95% CI: 0.18-0.30). Lower household transmissibility was reported in both child index cases and contacts than in adults (relative risk [RR] = 0.64, 95% CI: 0.50-0.81; RR = 0.74, 95% CI: 0.64-0.85). Younger children were as susceptible as the older children (RR = 0.89, 95% CI: 0.72-1.10). Through subgroup analyses of different variants and periods, increased household SAR was observed in children (Wild: 0.20; Alpha: 0.42; Delta: 0.35; Omicron: 0.56), and no significant difference was found in household SAR between children and adults when new variants dominated.

CONCLUSION

Although children were found not to be dominant in the household transmission, their transmissibility of SARS-CoV-2 appeared to be on the rise as new variants emerged.

摘要

目的

探讨新变异株流行时期儿童 SARS-CoV-2 的家庭传播性。

方法

通过检索 PubMed 和 Embase,纳入两部分研究:家庭二代发病率(SAR)的荟萃分析和家庭儿科感染的病例分析。

结果

共纳入 95 篇文献:48 篇用于荟萃分析,47 篇用于病例分析。儿童 COVID-19 仅占家庭传播的一小部分。儿童指数病例和接触者的家庭总 SAR 分别为 0.20(95%置信区间[CI]:0.15-0.26)和 0.24(95%CI:0.18-0.30)。与成人相比,儿童指数病例和接触者的家庭传播率均较低(相对风险[RR] = 0.64,95%CI:0.50-0.81;RR = 0.74,95%CI:0.64-0.85)。年龄较小的儿童与年龄较大的儿童一样易感(RR = 0.89,95%CI:0.72-1.10)。通过不同变异株和时期的亚组分析,儿童的家庭 SAR 增加(野生型:0.20;Alpha 型:0.42;Delta 型:0.35;Omicron 型:0.56),而当新变异株占主导地位时,儿童和成人的家庭 SAR 无显著差异。

结论

尽管儿童在家庭传播中并不占主导地位,但随着新变异株的出现,儿童 SARS-CoV-2 的传播能力似乎有所上升。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e7e/9091150/89409445315c/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e7e/9091150/4d275e8f25f0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e7e/9091150/d67b92dd3d43/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e7e/9091150/f97cb863ad10/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e7e/9091150/89409445315c/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e7e/9091150/4d275e8f25f0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e7e/9091150/d67b92dd3d43/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e7e/9091150/f97cb863ad10/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e7e/9091150/89409445315c/gr4_lrg.jpg

相似文献

1
The role of children in household transmission of COVID-19: a systematic review and meta-analysis.儿童在 COVID-19 家庭传播中的作用:系统评价和荟萃分析。
Int J Infect Dis. 2022 Sep;122:266-275. doi: 10.1016/j.ijid.2022.05.016. Epub 2022 May 11.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.SARS-CoV-2 中和单克隆抗体预防 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.工作场所干预措施以降低医疗机构外 SARS-CoV-2 感染的风险。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD015112. doi: 10.1002/14651858.CD015112.pub2.
6
Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.右雷佐生预防或减少接受蒽环类抗生素治疗的癌症成人和儿童的心脏毒性。
Cochrane Database Syst Rev. 2022 Sep 27;9(9):CD014638. doi: 10.1002/14651858.CD014638.pub2.
7
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
8
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
9
Enteral nutritional therapy for induction of remission in Crohn's disease.肠内营养疗法诱导克罗恩病缓解
Cochrane Database Syst Rev. 2018 Apr 1;4(4):CD000542. doi: 10.1002/14651858.CD000542.pub3.
10
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.

引用本文的文献

1
Age-dependent ACE2/TMPRSS2 expression and SARS-CoV-2 household transmission in Gran Canaria.大加那利岛年龄依赖性ACE2/TMPRSS2表达与新冠病毒家庭传播情况
PLoS One. 2025 Jul 29;20(7):e0329229. doi: 10.1371/journal.pone.0329229. eCollection 2025.
2
COVID-19 Seroprevalence in Romania: Insights from a Nationwide Antibody Study.罗马尼亚的新冠病毒血清流行率:一项全国性抗体研究的见解
Epidemiologia (Basel). 2025 Jun 4;6(2):26. doi: 10.3390/epidemiologia6020026.
3
A community-based cross-sectional survey of young children with SARS-CoV-2 infection during the Omicron wave in Beijing, China.

本文引用的文献

1
Household Transmission and Symptomology of Severe Acute Respiratory Syndrome Coronavirus 2 Alpha Variant among Children-California and Colorado, 2021.家庭传播和 2021 年加利福尼亚州和科罗拉多州儿童中严重急性呼吸综合征冠状病毒 2 阿尔法变异株的症状学。
J Pediatr. 2022 Aug;247:29-37.e7. doi: 10.1016/j.jpeds.2022.04.032. Epub 2022 Apr 18.
2
Transmission dynamics of COVID-19 in household and community settings in the United Kingdom, January to March 2020.2020 年 1 月至 3 月英国家庭和社区环境中 COVID-19 的传播动力学。
Euro Surveill. 2022 Apr;27(15). doi: 10.2807/1560-7917.ES.2022.27.15.2001551.
3
Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.
在中国北京奥密克戎毒株流行期间,一项针对感染新型冠状病毒2型的幼儿的社区横断面调查。
BMJ Open. 2025 Jun 8;15(6):e094749. doi: 10.1136/bmjopen-2024-094749.
4
Living With School-Aged Children and the Risk of Absenteeism Among Healthcare Workers During the Twindemic of COVID-19 and Influenza.在新冠疫情和流感双重流行期间与学龄儿童同住及医护人员旷工风险
Influenza Other Respir Viruses. 2025 Apr;19(4):e70100. doi: 10.1111/irv.70100.
5
Factors Associated With the Transmission of the Delta Severe Acute Respiratory Syndrome Coronavirus 2 Variant in Households: The Israeli COVID-19 Family Study (ICoFS).家庭中与德尔塔严重急性呼吸综合征冠状病毒2变种传播相关的因素:以色列新冠病毒家庭研究(ICoFS)
J Infect Dis. 2025 Apr 15;231(4):e734-e742. doi: 10.1093/infdis/jiaf001.
6
SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022.2021年6月至2022年2月期间,在荷兰社区检测点接受检测的有症状的接种疫苗成年人中的新冠病毒危险因素。
PLoS One. 2024 Dec 30;19(12):e0311229. doi: 10.1371/journal.pone.0311229. eCollection 2024.
7
Dynamics of SARS-CoV-2 lineages in children and adults in 2021 and 2022.2021年和2022年儿童及成人中新型冠状病毒谱系的动态变化
PLoS One. 2024 Dec 20;19(12):e0316213. doi: 10.1371/journal.pone.0316213. eCollection 2024.
8
Association between age of paediatric index cases and household SARS-CoV-2 transmission.儿科病例发病年龄与家庭内 SARS-CoV-2 传播的关系。
Epidemiol Infect. 2024 Nov 20;152:e145. doi: 10.1017/S0950268824000918.
9
High SARS-CoV-2 secondary infection rates in households with children in Georgia, United States, Fall 2020-Winter 2021.2020 年秋季至 2021 年冬季美国佐治亚州有儿童的家庭中 SARS-CoV-2 二次感染率较高。
Front Public Health. 2024 Oct 25;12:1378701. doi: 10.3389/fpubh.2024.1378701. eCollection 2024.
10
Factors Associated With Transmission Across Three Waves of SARS-CoV-2 in a Prospective Community-Based Study of Households With School-Aged Children-Dane County, Wisconsin, 2020-2022.与 2020-2022 年威斯康星州戴恩县学龄儿童家庭为基础的前瞻性社区研究中 SARS-CoV-2 经三波传播相关的因素。
Influenza Other Respir Viruses. 2024 Nov;18(11):e70031. doi: 10.1111/irv.70031.
家庭中未接种疫苗的无症状和有症状的 SARS-CoV-2 感染的家庭成员之间的 SARS-CoV-2 传播:一项抗体监测研究。
CMAJ Open. 2022 Apr 12;10(2):E357-E366. doi: 10.9778/cmajo.20220026. Print 2022 Apr-Jun.
4
Increased Secondary Attack Rate among Unvaccinated Household Contacts of Coronavirus Disease 2019 Patients with Delta Variant in Japan.日本,德尔塔变异株感染的 2019 冠状病毒病患者的未接种疫苗的家庭接触者中二次攻击率增加。
Int J Environ Res Public Health. 2022 Mar 24;19(7):3889. doi: 10.3390/ijerph19073889.
5
Risk of hospitalisation and death in children with SARS-CoV-2 delta (B.1.612.2) infection.感染新冠病毒德尔塔变异株(B.1.612.2)的儿童的住院和死亡风险。
Lancet Child Adolesc Health. 2022 May;6(5):e16-e17. doi: 10.1016/S2352-4642(22)00096-7. Epub 2022 Mar 29.
6
Unvaccinated Children Are an Important Link in the Transmission of SARS-CoV-2 Delta Variant (B1.617.2): Comparative Clinical Evidence From a Recent Community Surge.未接种疫苗的儿童是 SARS-CoV-2 德尔塔变异株(B1.617.2)传播的重要环节:近期社区疫情中的比较临床证据。
Front Cell Infect Microbiol. 2022 Mar 8;12:814782. doi: 10.3389/fcimb.2022.814782. eCollection 2022.
7
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Pediatric Age on Delta Variant Household Transmission.严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 疫苗接种和儿童年龄对德尔塔变异株家庭传播的影响。
Clin Infect Dis. 2022 Aug 24;75(1):e35-e43. doi: 10.1093/cid/ciac219.
8
Age-Varying Susceptibility to the Delta Variant (B.1.617.2) of SARS-CoV-2.新冠病毒德尔塔变异株(B.1.617.2)的年龄相关易感性。
JAMA Netw Open. 2022 Mar 1;5(3):e223064. doi: 10.1001/jamanetworkopen.2022.3064.
9
Hospitalization of Infants and Children Aged 0-4 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022.0-4 岁确诊感染 COVID-19 的婴幼儿住院情况-COVID-NET,14 个州,2020 年 3 月-2022 年 2 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 18;71(11):429-436. doi: 10.15585/mmwr.mm7111e2.
10
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022.2 剂 BNT162b2(辉瑞-生物科技)mRNA 疫苗预防 5-11 岁儿童和 12-15 岁青少年感染 SARS-CoV-2 的效果 - PROTECT 队列,2021 年 7 月至 2022 年 2 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 18;71(11):422-428. doi: 10.15585/mmwr.mm7111e1.